https://www.has-sante.fr/jcms/p_3574250/fr/eladynos-abaloparatide-osteoporose 2025 false false false France abaloparatide Product containing only abaloparatide in parenteral dose form (medicinal product form) treatment outcome insurance, health, reimbursement osteoporotic fractures History of vertebral fracture (situation) History of osteoporotic fracture (situation) injections, subcutaneous bone density conservation agents evaluation of the transparency committee osteoporosis, postmenopausal abaloparatide
--- https://www.ema.europa.eu/en/medicines/human/EPAR/eladynos 2023 false false false Netherlands French English treatment outcome drug evaluation abaloparatide abaloparatide summary of product characteristics package leaflet syndication feed abaloparatide drug approval europe osteoporosis, postmenopausal osteoporotic fractures injections, subcutaneous bone density conservation agents bone density conservation agents product surveillance, postmarketing drug interactions drug evaluation, preclinical parathyroid hormone-related protein
--- https://www.cadth.ca/fr/abaloparatide 2022 false false false Canada French drug evaluation canada abaloparatide bone density conservation agents abaloparatide